Abstract
e15747Background: Resistance of pancreatic adenocarcinoma (PDA) to therapy remains a challenge. One factor of the barrier is the T-lymphocyte driven inflammatory response seen in PDA. The CTLA-4 T-...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
